Skip to content

5-MeO-DMT: all studies

Page 79 of 110: studies 781 to 790 of 1,096, newest first. Back to the 5-MeO-DMT overview

Research

Psychedelic Treatment for Trauma-Related Psychological and Cognitive Impairment Among US Special Operations Forces Veterans

Chronic Stress August 12, 2020 Alan K. Davis, Lynnette A. Averill, Nathan D. Sepeda et al. 83 citations

Background U.S. Special Operations Forces Veterans are at increased risk for a variety of mental health problems and cognitive impairment associated with military service. Current treatments are lacking in effectiveness and adherence. Therefore, this study examined psychedelic treatment with ibogaine and 5-methoxy-N,N-dimethyltryptamine for trauma-related psychological and cognitive impairment...

DOI: 10.1177/2470547020939564 (opens in new tab) Full text (opens in new tab) Psychedelic therapy Veteran mental health Trauma recovery Cognitive improvement

Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms

Journal of Pharmaceutical and Biomedical Analysis July 21, 2020 Izumi Morita, Hiroyuki Oyama, Yuki Kiguchi et al. 17 citations

Development of rapid and reliable immunochemical methods for monitoring psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine; Pyb) and psilocin (dephosphorylated metabolite; Psi), the psychoactive compounds contained within hallucinogenic mushrooms (magic mushrooms), is desirable in order to identify these mushrooms and regulate their illicit use. Because no antibody was publicly available for...

DOI: 10.1016/j.jpba.2020.113485 (opens in new tab) Psilocybin Hallucinogen Monoclonal antibody Metabolite +3

Biodiversity of β-Carboline Profile of Banisteriopsis caapi and Ayahuasca, a Plant and a Brew with Neuropharmacological Potential

Plants July 9, 2020 Beatriz Werneck Lopes Santos, Regina Célia de Oliveira, Júlia Sonsin‐oliveira et al. 32 citations

Ayahuasca is a psychoactive infusion with a large pharmacological application normally prepared with Banisteriopsis caapi, which contains the monoamine oxidase inhibitors β-carbolines, and Psichotria virids, which contains the serotonin receptor agonist N,N dimethyltryptamine (DMT). The objectives of this study were to investigate the chemical profile of B. caapi and of ayahuasca collected in...

DOI: 10.3390/plants9070870 (opens in new tab) Ayahuasca Harmine Harmaline Malpighiaceae +4

DMT analogues: N-ethyl-N-propyltryptamine and N-allyl-N-methytryptamine as their hydrofumarate salts

Acta Crystallographica. Section E, Crystallographic Communications July 3, 2020 Andrew R Chadeayne, Duyen N. K. Pham, James A. Golen et al.

The structures of the hydrofumarate salts of two N,N-dimethyltryptamine (DMT) derivatives, the synthetic psychedelics N-ethyl-N-propyltryptamine (EPT) and N-allyl-N-methyltryptamine (MALT), are reported.

The pharmacological interaction of compounds in ayahuasca: a systematic review

Brazilian Journal of Psychiatry July 3, 2020 Simon Ruffell, Nige Netzband, Catherine Bird et al. 43 citations

Ayahuasca is a South American psychoactive plant brew used as traditional medicine in spiritual and in cultural rituals. This is a review of the current understanding about the pharmacological mechanisms that may be interacting in ayahuasca. Searches were performed using PubMed, PsycINFO, and Web of Science databases and 16 papers were selected. As hypothesized, the primary narrative in...

Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease.

Journal of Ethnopharmacology June 12, 2020 Albert Katchborian‐neto, Wanderleya T Santos, Karen J Nicácio et al. 62 citations

Ayahuasca is a tea produced through decoction of Amazonian plants. It has been used for centuries by indigenous people of South America. The beverage is considered to be an ethnomedicine, and it is traditionally used for the treatment of a wide range of diseases, including neurological illness. Besides, some scientific evidence suggests it may be applicable to Parkinson's disease (PD)...

DOI: 10.1016/j.jep.2020.112743 (opens in new tab) Full text (opens in new tab) Ayahuasca Metabolomics Neurodegenerative disease Neuroprotection +2

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy

Journal of Psychoactive Drugs June 12, 2020 Jason B. Luoma, Christina Chwyl, Geoff J. Bathje et al. 206 citations

After a two-decade hiatus in which research on psychedelics was essentially halted, placebo-controlled clinical trials of psychedelic-assisted therapy for mental health conditions have begun to be published. We identified nine randomized, placebo-controlled clinical trials of psychedelic-assisted therapy published since 1994. Studies examined psilocybin, LSD (lysergic acid diethylamide),...

Psilocybin: from ancient magic to modern medicine

The Journal of Antibiotics May 12, 2020 David E. Nichols 184 citations

Psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) is an indole-based secondary metabolite produced by numerous species of mushrooms. South American Aztec Indians referred to them as teonanacatl, meaning "god's flesh," and they were used in religious and healing rituals. Spanish missionaries in the 1500s attempted to destroy all records and evidence of the use of these mushrooms. Nevertheless,...

DOI: 10.1038/s41429-020-0311-8 (opens in new tab) Psilocybin Magic telescope Hallucinogen Traditional medicine +2

Ayahuasca – potential therapeutic properties in psychiatry. Research review

Psychiatria Polska April 30, 2020 Aleksandra Barabasz-Gembczyk, Krzysztof Kucia 4 citations

Ayahuaska, zwana również „lianą duszy”, „pnączem duszy” to rytualny psychodelik podawany tradycyjnie w formie wywaru roślinnego, od stuleci stosowany przez rdzenną ludność Ameryki Południowej, a w ostatnich 25 latach również w krajach Europy, Azji, Afryki, Australii, w Kanadzie i Stanach Zjednoczonych Ameryki Północnej. Jej aktywność biologiczna wynika z zawartości N,N- dimetrylotryptaminy...

A rapid analytical strategy for the determination of ayahuasca alkaloids in non-ritualistic approaches by UHPLC-MS/MS

Forensic Science International April 17, 2020 Sarah Eller, Gabriela Ramos Borges, Daniela Souza Ossanes et al. 13 citations

IntroductionAyahuasca is a beverage composed by a mixture of herbs which contain the compound N,N-dimethyltriptamine (DMT) and the β-carbolines. Although its use is legalized in Brazil only for religious and spiritual ceremonies, there is a growing black market specialized in the distribution of these compounds in form of herbal material through internet and mail. The purpose of this work was...